Precision Neuroscience
Precision Neuroscience is a brain-computer interface company developing minimally invasive, implantable neural technology, including its flagship Layer 7 Cortical Interface, to read and interpret brain signals and help patients affected by neurological conditions such as paralysis.
Analytics date: 03.11.2026
Basic information
Head office
54 West 21st Street, Suite 310, New York, NY 10010, United StatesHead officeGeography of business
United States of AmericaGeography of businessDate of the last round
Last round 09/2026Date of the last roundTotal funds raised
$429.1M+Total funds raisedPrice per share
$8.10Price per sharePrice per share. Based on the latest known transaction. It is not an offer or investment recommendation.
Analytics date: 03.11.2026
IPO Forecast
No reliable, verifiable statements from Precision Neuroscience executives, official filings, or credible financial media could be located that specified a target IPO date or expected valuation for an initial public offering. As a result, no confirmed IPO timeline or forecast valuation can be reported at this time.
Request price
Competitor Analysis
Comparison with other companies in the industry.
| Name | Valuation |
| Private companies | |
Neuralink | 0000 |
Merge Labs | 00000 |
Isomorphic Labs | 00 |
NaturalCycles | 00000 |
Flo Health | 00000 |
| Traded companies | |
NeuroMetrix | 00000 |
NeuroPace | 00000 |
Recursion Pharmaceuticals | 00000 |
Schrödinger | 00000 |
Relay Therapeutics | 00 |